Covered recipient · General Payments record
GEORGE N KIMMERLING
General Payments · PY2018–2024
$2,403.95
- Reported across 118 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $613.63 | 28 |
| Education | $14.52 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $220.40 | 10 |
| Novo Nordisk AS | $191.21 | 10 |
| Amgen Inc. | $105.76 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $43.19 | 2 |
| Abbott Laboratories | $28.85 | 1 |
| DEXCOM, INC. | $24.22 | 1 |
| Radius Health, Inc. | $14.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $28.85 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125371544 | CMS |
| Amgen Inc. | $24.69 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620340 | CMS |
| Amgen Inc. | $29.49 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620336 | CMS |
| Amgen Inc. | $29.46 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620338 | CMS |
| Amgen Inc. | $22.12 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620334 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.74 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117972495 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.45 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117972493 | CMS |
| Dexcom, Inc. | $24.22 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153301359 | CMS |
| Lilly USA, LLC | $17.73 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985532 | CMS |
| Lilly USA, LLC | $31.97 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134997872 | CMS |
| Lilly USA, LLC | $15.35 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134998034 | CMS |
| Lilly USA, LLC | $2.83 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135004939 | CMS |
| Lilly USA, LLC | $31.58 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985888 | CMS |
| Lilly USA, LLC | $25.15 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985150 | CMS |
| Lilly USA, LLC | $32.23 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985146 | CMS |
| Lilly USA, LLC | $19.40 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985148 | CMS |
| Lilly USA, LLC | $20.61 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135004941 | CMS |
| Lilly USA, LLC | $23.55 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135004943 | CMS |
| Novo Nordisk Inc | $24.75 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097351143 | CMS |
| Novo Nordisk Inc | $10.58 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097370707 | CMS |
| Novo Nordisk Inc | $13.50 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096678631 | CMS |
| Novo Nordisk Inc | $19.54 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097580243 | CMS |
| Novo Nordisk Inc | $16.30 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097615257 | CMS |
| Novo Nordisk Inc | $24.29 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096918062 | CMS |
| Novo Nordisk Inc | $21.59 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097192927 | CMS |
| Novo Nordisk Inc | $15.01 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097450884 | CMS |
| Novo Nordisk Inc | $18.18 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096941521 | CMS |
| Novo Nordisk Inc | $27.47 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097708314 | CMS |
| Radius Health, Inc. | $14.52 | 10/08/2024 | Education | Undisputed | 01/23/2026 | 1089953034 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.